anaplastic thyroid cancer atc also known anaplastic thyroid carcinoma aggressive form thyroid cancer characterized uncontrolled growth cells thyroid gland form cancer generally carries poor prognosis due aggressive behavior resistance cancer cells anaplastic thyroid cancer highly abnormal usually longer resemble original thyroid cells poor differentiation atc uncommon form thyroid cancer accounting cases due high mortality responsible deaths thyroid median survival time diagnosis three six studies report survive year survival occurs commonly women men seen commonly people ages anaplastic thyroid cancer typically manifests rapidly enlarging neck associated redness swelling overlying skin sometimes occur atc commonly causes symptoms compressing local structures esophagus carotid arteries recurrent laryngeal nerve trachea compression local anatomic structures may cause symptoms difficulty controlling voice hoarseness difficulty swallowing trouble symptoms include cough neck pain symptoms spread cancer distant sites body brain atc may rarely present coughing risk factors include age sixty longstanding goiter repeated radiation exposure chest neck nearly half atc cases occur setting coexisting differentiated thyroid cancer suggests many atc cases dedifferentiated differentiated thyroid cancer result become aggressive difficult treat differentiated thyroid cancer seen coexisting atc fineneedle aspiration biopsies anaplastic tumors high mitotic rate frequently invades local blood lymphatic cellular death frequently visualized microscopic presence regionally swollen lymph nodes older patients needle aspiration biopsy reveals characteristic vesicular appearance nuclei supports diagnosis anaplastic carcinoma microscopic images atc usually show inflammatory cells immune system cells immunohistochemistry testing atc usually positive keratin proteins negative thyroid transcription thyroglobulin atc cells demonstrate high levels braf tert mutations seen commonly atc differentiated thyroid fineneedle aspiration essential order obtain sample thyroid tissue allow microscopic examination allows experienced pathologist differentiate atc diseases forms thyroid important distinguish atc poorlydifferentiated thyroid cancer distinction difficult presence positive staining association different thyroid cancer adjacent atc support atc divided several different subclasses based microscopic characteristics include sarcomatoid squamoid osteoclastic paucicellular rhabdoid carcinomasarcoid despite fact atc subtypes recognized classification led differences atc always considered stage iv reliable laboratory tests ultrasound imaging atc lesions reveals hypoechoic mass appears dark ultrasound invasion local structures may help better characterize presence absence neck lymph node surgery planned however contrastenhanced computed tomography ct scan neck must pet scan preferred staging atc ct scan neck chest abdomen pelvis substituted former magnetic resonance imaging mri brain also recommended assess distant addition atc rapidly enlarging neck mass prompts consideration several important diagnoses include cancers primary thyroid lymphoma poorly differentiated thyroid cancer sarcomas metastases cancers upper digestive tract respiratory squamous cell carcinoma thyroid gland rare cause atc considered emergency cancer diagnosis since poses high risk blocking airway andor esophagus due rapid growth neck either quickly cause persons death asphyxiation immediately unlike differentiated counterparts anaplastic thyroid cancer highly unlikely curable either surgery treatment modality fact usually unresectable due high propensity invading surrounding multidisciplinary team including endocrine pathologist head neck surgeon medical oncologist radiation oncologist endocrinologist palliative care physician essential optimal palliative treatment consists radiation therapy usually combined chemotherapy use tracheostomy part supportive care atc medications fosbretabulin type combretastatin bortezomib tnfrelated apoptosis induced ligand trail however investigation vitro human clinical studies based encouraging phase ii clinical trial results type medication selectively destroys tumor blood vessels clinical trials evaluating whether medication extend survival patients advent molecular testing nextgeneration sequencing braf mek inhibitors playing increasing role management patients anaplastic thyroid cancer harboring mutations combination dabrafenib trametinib shown significant increases overall survival approved fda another similar combination vemurafenib cobimetinib immunotherapy also starting play important role anaplastic thyroid cancer management several ongoing clinical trials demonstrating promising effects specific drugs tested atezolizumab pembrolizumab spartalizumab amongst others combinatorial therapy molecularbased may lead significant tumor regression potentially making patients amenable curative role external beam radiotherapy ebrt thyroid cancer remains controversial level evidence recommend use setting differentiated thyroid cancers papillary follicular carcinomas anaplastic thyroid carcinomas however histologically distinct differentiated thyroid cancers due highly aggressive nature atc aggressive postoperative radiation chemotherapy typically recommended national comprehensive cancer network clinical practice guidelines currently recommend postoperative radiation chemotherapy strongly considered published randomized controlled trials examined addition ebrt standard treatment namely surgery radioactive iodine typically ineffective management atc iodineavid imbalances age sex completeness surgical excision histological type stage patients receiving receiving ebrt confound retrospective studies variability also exists treatment nontreatment groups use radioiodine posttreatment thyroid stimulating hormone tsh suppression treatment techniques within retrospective studies recent studies indicated ebrt may promising though number patients studies clinical trials investigational treatments often considered healthcare professionals patients firstline treatment absence extracervical unresectable disease surgical excision followed adjuvant radiotherapy patients whose tumour seems confined neck grossly resectable complete surgical resection followed adjuvant radiotherapy chemotherapy could yield survival years number clinical trials anaplastic thyroid carcinoma underway overall survival rate anaplastic thyroid cancer given although latter criticized additional factors affect prognosis include persons age presence distant metastases dose radiation administered primary tumor regional lymph nodes combined modality treatment treatment anaplastic thyroid cancer generally palliative intent due highly aggressive nature nearly universal mortality larger tumors distant metastases acute obstructive symptoms leukocytosis portend poorer prognosis death attributable upper airway obstruction suffocation half patients combination complications local distant disease therapy remainder anaplastic thyroid cancer extremely aggressive historically cases death occurs less year result aggressive local growth compromise vital structures neck atc series median survival months time diagnosis rare longterm recent data however suggests patients mutated disease even advanced stage may significantly better prognosis novel targeted therapies extend tumor control considerably also leading tumor burden decrease potentially make patients candidates recent advances show using combination novel targeted therapies immunotherapy surgery year year survival anaplastic thyroid cancer patients increased httpsenwikipediaorgwikianaplasticthyroidcancer